Steven K Rowe MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Join to View Full Profile
3428 N Roosevelt BlvdKey West, FL 33040
Phone+1 305-294-5727
Fax+1 305-294-1506
Dr. Rowe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Cardiovascular Disease, 1987 - 1990
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1984 - 1987
University of Missouri-Columbia School of MedicineClass of 1984
Certifications & Licensure
FL State Medical License 2003 - 2026
MO State Medical License 1984 - 2026
KS State Medical License 1990 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral Start of enrollment: 2009 Aug 04
- Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- 3 citationsFinal 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Stu...David E. Kandzari, Nima Amjadi, Christopher Caputo, Steven K. Rowe, Henry Chen
The American Journal of Cardiology. 2019-06-01 - 17 citationsOne-Year Outcomes in “Real-World” Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study ...David E. Kandzari, Nima Amjadi, Christopher Caputo, Steven K. Rowe, Jerome Williams
The American Journal of Cardiology. 2016-02-15 - 131 citationsAlcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.Sherif F. Nagueh, Bertron M. Groves, Leonard Schwartz, Karen M. Smith, Andrew Wang
Journal of the American College of Cardiology. 2011-11-22
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
